Literature DB >> 15844719

Intestinal permeability in long-term follow-up of patients with celiac disease on a gluten-free diet.

D R Duerksen1, C Wilhelm-Boyles, D M Parry.   

Abstract

Intestinal permeability is frequently abnormal in patients with celiac disease. The long-term effect of a gluten-free diet on intestinal permeability and the correlation of intestinal permeability with a gluten-free diet are not known. The objectives of this study were to determine the responses of intestinal permeability and antibody testing to gluten free diet and the degree of correlation of these measurements with gluten ingestion. In this prospective study, patients with celiac disease were divided into three groups based on length of time on a gluten-free diet: Group A, < 1 month; Group B, 1 month-1 year; Group C, > 1 year. Patients in Groups B and C were tested at baseline and at 4-12 weeks later for the following: lactulose/mannitol intestinal permeability, endomysial antibody, and 3-day food record. Permeability tests were also performed in Group A and control subjects. Intestinal permeability was elevated in newly diagnosed celiac disease and in individuals on a gluten-free diet for less than 1 year. Intestinal permeability was normal in 80% at visit 1 and 87% at visit 2 in individuals with celiac disease on a gluten-free diet for more than a year. Trace gluten ingestion was associated with increased intestinal permeability on visit 2 (P = 0.0480). The sensitivity of detecting gluten ingestion as measured by a 3-day food record was higher for permeability testing (29 and 36%) compared with endomysial antibody testing (18 and 18%) for visits 1 and 2, respectively. Intestinal permeability normalizes in the majority of individuals with celiac disease on a gluten-free diet. Gluten ingestion as measured by a 3-day food record correlates with intestinal permeability measurements. The role of permeability testing in the follow-up of patients with celiac disease warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15844719     DOI: 10.1007/s10620-005-2574-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  31 in total

Review 1.  The widening spectrum of celiac disease.

Authors:  J A Murray
Journal:  Am J Clin Nutr       Date:  1999-03       Impact factor: 7.045

2.  [Value of the intestinal permeability test with lactulose-mannitol for screening and monitoring of celiac disease in children].

Authors:  L Leke; E Barau; J P Barbet; S Epelbaum; Y Vierin; C Dupont
Journal:  Arch Fr Pediatr       Date:  1992-01

3.  Intestinal permeability after single dose gluten challenge in coeliac disease.

Authors:  L Greco; G D'Adamo; A Truscelli; G Parrilli; M Mayer; G Budillon
Journal:  Arch Dis Child       Date:  1991-07       Impact factor: 3.791

4.  Compliance of adolescents with coeliac disease with a gluten free diet.

Authors:  M Mayer; L Greco; R Troncone; S Auricchio; M N Marsh
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

5.  Small bowel permeability in diagnosis of celiac disease and monitoring of compliance of a gluten-free diet (gut permeability in celiac disease).

Authors:  P Kohout
Journal:  Acta Medica (Hradec Kralove)       Date:  2001

6.  Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease.

Authors:  A Fasano; T Not; W Wang; S Uzzau; I Berti; A Tommasini; S E Goldblum
Journal:  Lancet       Date:  2000-04-29       Impact factor: 79.321

7.  Need for follow up in coeliac disease.

Authors:  M T Bardella; N Molteni; L Prampolini; A M Giunta; A R Baldassarri; D Morganti; P A Bianchi
Journal:  Arch Dis Child       Date:  1994-03       Impact factor: 3.791

8.  Screening for coeliac disease: the meaning of low titers of anti-gliadin antibodies (AGA) in non-coeliac children.

Authors:  M Bonamico; G Ballati; P Mariani; M Latini; P Triglione; I Rana; E Porro; M A Mesturino; S Criscione
Journal:  Eur J Epidemiol       Date:  1997-01       Impact factor: 8.082

9.  The gluten-free diet: a nutritional risk factor for adolescents with celiac disease?

Authors:  P Mariani; M G Viti; M Montuori; A La Vecchia; E Cipolletta; L Calvani; M Bonamico
Journal:  J Pediatr Gastroenterol Nutr       Date:  1998-11       Impact factor: 2.839

10.  Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function.

Authors:  M G Clemente; S De Virgiliis; J S Kang; R Macatagney; M P Musu; M R Di Pierro; S Drago; M Congia; A Fasano
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

View more
  32 in total

Review 1.  Alterations in intestinal permeability.

Authors:  M C Arrieta; L Bistritz; J B Meddings
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

2.  Anti-Saccharomyces cerevisiae antibodies in primary biliary cirrhosis.

Authors:  Wahiba Sakly; Moncef Jeddi; Ibtissem Ghedira
Journal:  Dig Dis Sci       Date:  2007-11-30       Impact factor: 3.199

Review 3.  The measurement and clinical significance of intestinal permeability.

Authors:  Christopher W Teshima; Jon B Meddings
Journal:  Curr Gastroenterol Rep       Date:  2008-10

Review 4.  Intestinal mucosal barrier function in health and disease.

Authors:  Jerrold R Turner
Journal:  Nat Rev Immunol       Date:  2009-11       Impact factor: 53.106

5.  Intestinal permeability in subjects from two different race groups with diverse stone-risk profiles.

Authors:  Takalani Theka; Allen Rodgers; Neil Ravenscroft; Sonja Lewandowski
Journal:  Urolithiasis       Date:  2013-01-22       Impact factor: 3.436

6.  Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease.

Authors:  Daniel Leffler; Detlef Schuppan; Kumar Pallav; Robert Najarian; Jeffery D Goldsmith; Joshua Hansen; Toufic Kabbani; Melinda Dennis; Ciarán P Kelly
Journal:  Gut       Date:  2012-05-22       Impact factor: 23.059

7.  Interferon-gamma released by gluten-stimulated celiac disease-specific intestinal T cells enhances the transepithelial flux of gluten peptides.

Authors:  Michael T Bethune; Matthew Siegel; Samuel Howles-Banerji; Chaitan Khosla
Journal:  J Pharmacol Exp Ther       Date:  2009-02-13       Impact factor: 4.030

Review 8.  PXR: More Than Just a Master Xenobiotic Receptor.

Authors:  Peter O Oladimeji; Taosheng Chen
Journal:  Mol Pharmacol       Date:  2017-11-07       Impact factor: 4.436

9.  Noninflammatory gluten peptide analogs as biomarkers for celiac sprue.

Authors:  Michael T Bethune; Mónica Crespo-Bosque; Elin Bergseng; Kaushiki Mazumdar; Lara Doyle; Karol Sestak; Ludvig M Sollid; Chaitan Khosla
Journal:  Chem Biol       Date:  2009-08-28

10.  A comparison of antibody testing, permeability testing, and zonulin levels with small-bowel biopsy in celiac disease patients on a gluten-free diet.

Authors:  D R Duerksen; C Wilhelm-Boyles; R Veitch; D Kryszak; D M Parry
Journal:  Dig Dis Sci       Date:  2009-04-28       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.